Serous retinal detachment and cystoid macular edema in a patient with Wyburn-Mason syndrome.

Abstract

Wyburn-Mason syndrome is a rare phacomatosis characterized by unilateral arteriovenous malformations (AVMs) involving the brain, retina, and (rarely) the skin. The diagnosis is concluded with dilated fundus examination and markedly dilated tortuous vascular loops with arteriovenous communications on fluorescent angiography. We present a 14-year-old male patient with Wyburn-Mason syndrome who developed serous macular neuroretinal detachment, cystoid macular edema (CME), and consequent visual deterioration in the left eye. To the best of our knowledge, this is the first report of a patient with Wyburn-Mason syndrome who developed serous retinal detachment and CME.

• Authors: Halil Ibrahim Onder, Sibel Alisan, Murat Tunc
• Journal: Seminars in ophthalmology (Semin Ophthalmol) Vol. 30 Issue 2 Pg. 154-6 (Mar 2015) ISSN: 1744-5205 [Electronic] England
• PMID: 24171831 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Antihypertensive Agents
• Glucocorticoids
• Sulfonamides
• Thiophenes
• Ketorolac Tromethamine
• prednisolone acetate
• dorzolamide
• Prednisolone
• Triamcinolone Acetonide

Topics

• Adolescent
• Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
• Antihypertensive Agents (therapeutic use)
• Arteriovenous Fistula (complications, diagnosis)
• Drug Therapy, Combination
• Fluorescein Angiography
• Glucocorticoids (therapeutic use)
• Humans
• Ketorolac Tromethamine (therapeutic use)
• Macular Edema (diagnosis, drug therapy, etiology)
• Magnetic Resonance Imaging
• Male
• Neurocutaneous Syndromes (complications, diagnosis)
• Prednisolone (analogs & derivatives, therapeutic use)
• Retinal Detachment (diagnosis, drug therapy, etiology)
• Subretinal Fluid
• Sulfonamides (therapeutic use)
• Thiophenes (therapeutic use)
• Tomography, Optical Coherence
• Triamcinolone Acetonide (therapeutic use)